{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:45:11Z","timestamp":1775483111339,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Research Grant of Nanjing TANTICA Co. Ltd","award":["2021TC01.1"],"award-info":[{"award-number":["2021TC01.1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02785-0","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:11:23Z","timestamp":1766398283000},"page":"805-817","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and validation of PARP4 methylation in distinguishing thyroid cancer from benign nodule"],"prefix":"10.1007","volume":"49","author":[{"given":"Mengxia","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6655-1986","authenticated-orcid":false,"given":"Rongxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"2785_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911989","author":"HM Zhang","year":"2022","unstructured":"Zhang HM, Li ZY, Dai ZT, Wang J, Li LW, Zong QB, Li JP, Zhang TC, Liao XH (2022) Interaction of MRPL9 and GGCT promotes cell proliferation and migration by activating the MAPK\/ERK pathway in papillary thyroid cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231911989","journal-title":"Int J Mol Sci"},{"key":"2785_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"3","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 3:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"2785_CR3","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ecl.2017.04.011","volume":"3","author":"M Melany","year":"2017","unstructured":"Melany M, Chen S (2017) Thyroid cancer: ultrasound imaging and fine-needle aspiration biopsy. Endocrinol Metab Clin North Am 3:691\u2013711. https:\/\/doi.org\/10.1016\/j.ecl.2017.04.011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2785_CR4","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","volume":"11","author":"ES Cibas","year":"2017","unstructured":"Cibas ES, Ali SZ (2017) The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 11:1341\u20131346. https:\/\/doi.org\/10.1089\/thy.2017.0500","journal-title":"Thyroid"},{"key":"2785_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.845549","volume":"12","author":"V Cantisani","year":"2022","unstructured":"Cantisani V, De Silvestri A, Scotti V, Fresilli D, Tarsitano MG, Polti G, Guiban O, Polito E, Pacini P, Durante C, Grani G, Isidori AM, Giannetta E, Sorrenti S, Trimboli P, Catalano C, Cirocchi R, Lauro A, D\u2019Andrea V (2022) US-elastography with different techniques for thyroid nodule characterization: systematic review and meta-analysis. Front Oncol 845549. https:\/\/doi.org\/10.3389\/fonc.2022.845549","journal-title":"Front Oncol"},{"key":"2785_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/hed.26598","volume":"3","author":"T Todsen","year":"2021","unstructured":"Todsen T, Bennedbaek FN, Kiss K, Heged\u00fcs L (2021) Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules. Head Neck 3:1009\u20131013. https:\/\/doi.org\/10.1002\/hed.26598","journal-title":"Head Neck"},{"key":"2785_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415626","author":"AS Attia","year":"2022","unstructured":"Attia AS, Hussein M, Issa PP, Elnahla A, Farhoud A, Magazine BM, Youssef MR, Aboueisha M, Shama M, Toraih E, Kandil E (2022) Association of BRAF(V600E) mutation with the aggressive behavior of papillary thyroid microcarcinoma: a meta-analysis of 33 studies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232415626","journal-title":"Int J Mol Sci"},{"key":"2785_CR8","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/j.humpath.2015.06.001","volume":"10","author":"N Fnais","year":"2015","unstructured":"Fnais N, Soobiah C, Al-Qahtani K, Hamid JS, Perrier L, Straus SE, Tricco AC (2015) Diagnostic value of fine needle aspiration BRAF(V600E) mutation analysis in papillary thyroid cancer: a systematic review and meta-analysis. Hum Pathol 10:1443\u20131454. https:\/\/doi.org\/10.1016\/j.humpath.2015.06.001","journal-title":"Hum Pathol"},{"key":"2785_CR9","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/s0140-6736(18)31268-6","volume":"10149","author":"Y Dor","year":"2018","unstructured":"Dor Y, Cedar H (2018) Principles of DNA methylation and their implications for biology and medicine. Lancet 10149:777\u2013786. https:\/\/doi.org\/10.1016\/s0140-6736(18)31268-6","journal-title":"Lancet"},{"key":"2785_CR10","doi-asserted-by":"publisher","first-page":"R415","DOI":"10.1530\/erc-19-0093","volume":"7","author":"C Zafon","year":"2019","unstructured":"Zafon C, Gil J, P\u00e9rez-Gonz\u00e1lez B, Jord\u00e0 M (2019) DNA methylation in thyroid cancer. Endocr Relat Cancer 7:R415\u2013r439. https:\/\/doi.org\/10.1530\/erc-19-0093","journal-title":"Endocr Relat Cancer"},{"key":"2785_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/156652410790963303","volume":"2","author":"N Shivapurkar","year":"2010","unstructured":"Shivapurkar N, Gazdar AF (2010) DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med 2:123\u2013132. https:\/\/doi.org\/10.2174\/156652410790963303","journal-title":"Curr Mol Med"},{"key":"2785_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/cen.14192","volume":"2","author":"F Wei","year":"2020","unstructured":"Wei F, Wu Y, Wang Z, Li Y, Wang J, Shao G, Yang Y, Shi B (2020) Diagnostic significance of DNA methylation of PTEN and DAPK in thyroid tumors. Clin Endocrinol (Oxf) 2:187\u2013195. https:\/\/doi.org\/10.1111\/cen.14192","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2785_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-45","volume":"9","author":"B Zhang","year":"2014","unstructured":"Zhang B, Liu S, Zhang Z, Wei J, Qu Y, Wu K, Yang Q, Hou P, Shi B (2014) Analysis of BRAF(V600E) mutation and DNA methylation improves the diagnostics of thyroid fine needle aspiration biopsies. Diagn Pathol 45. https:\/\/doi.org\/10.1186\/1746-1596-9-45","journal-title":"Diagn Pathol"},{"key":"2785_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/cyt.12248","volume":"2","author":"H Chang","year":"2016","unstructured":"Chang H, Shin BK, Kim A, Kim HK, Kim BH (2016) DNA methylation analysis for the diagnosis of thyroid nodules - a pilot study with reference to BRAF(V) (600E) mutation and cytopathology results. Cytopathology 2:122\u2013130. https:\/\/doi.org\/10.1111\/cyt.12248","journal-title":"Cytopathology"},{"key":"2785_CR15","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40618-017-0702-2","volume":"2","author":"JK Stephen","year":"2018","unstructured":"Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ (2018) Methylation markers differentiate thyroid cancer from benign nodules. J Endocrinol Invest 2:163\u2013170. https:\/\/doi.org\/10.1007\/s40618-017-0702-2","journal-title":"J Endocrinol Invest"},{"key":"2785_CR16","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1089\/thy.2018.0458","volume":"9","author":"MC Barros-Filho","year":"2019","unstructured":"Barros-Filho MC, Dos Reis MB, Beltrami CM, de Mello JBH, Marchi FA, Kuasne H, Drigo SA, de Andra VP, Saieg MA, Pinto CAL, Kowalski LP, Rogatto SR (2019) DNA methylation-based method to differentiate malignant from benign thyroid lesions. Thyroid 9:1244\u20131254. https:\/\/doi.org\/10.1089\/thy.2018.0458","journal-title":"Thyroid"},{"key":"2785_CR17","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1158\/1078-0432.Ccr-18-0841","volume":"2","author":"JH Yim","year":"2019","unstructured":"Yim JH, Choi AH, Li AX, Qin H, Chang S, Tong ST, Chu P, Kim BW, Schmolze D, Lew R, Ibrahim Y, Poroyko VA, Salvatierra S, Baker A, Wang J, Wu X, Pfeifer GP, Fong Y, Hahn MA (2019) Identification of tissue-specific DNA methylation signatures for thyroid nodule diagnostics. Clin Cancer Res 2:544\u2013551. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-0841","journal-title":"Clin Cancer Res"},{"key":"2785_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2217\/epi-2023-0338","volume":"23","author":"J Li","year":"2023","unstructured":"Li J, Yin Y, Huang H, Li M, Li H, Zhang M, Jiang C, Yang R (2023) RUNX1 methylation as a cancer biomarker in differentiating papillary thyroid cancer from benign thyroid nodules. Epigenomics 23:1257\u20131272. https:\/\/doi.org\/10.2217\/epi-2023-0338","journal-title":"Epigenomics"},{"key":"2785_CR19","doi-asserted-by":"publisher","first-page":"L7","DOI":"10.1530\/erc-17-0453","volume":"3","author":"L Lamartina","year":"2018","unstructured":"Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, Bellantone R, Pontecorvi A, Montesano T, Pagano L, Daniele L, Fugazzola L, Ceresini G, Bruno R, Rossetto R, Tumino S, Centanni M, Meringolo D, Castagna MG, Salvatore D, Nicolucci A, Lucisano G, Filetti S, Durante C (2018) 8th edition of the AJCC\/TNM staging system of thyroid cancer: what to expect (ITCO#2). Endocr Relat Cancer 3:L7\u2013l11. https:\/\/doi.org\/10.1530\/erc-17-0453","journal-title":"Endocr Relat Cancer"},{"key":"2785_CR20","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/carcin\/bgx004","volume":"3","author":"R Yang","year":"2017","unstructured":"Yang R, St\u00f6cker S, Schott S, Heil J, Marme F, Cuk K, Chen B, Golatta M, Zhou Y, Sutter C, Wappenschmidt B, Schmutzler R, Bugert P, Qu B, Bartram CR, Sohn C, Schneeweiss A, Burwinkel B (2017) The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies. Carcinogenesis 3:312\u2013320. https:\/\/doi.org\/10.1093\/carcin\/bgx004","journal-title":"Carcinogenesis"},{"key":"2785_CR21","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1002\/hed.25691","volume":"7","author":"MJ Hu","year":"2019","unstructured":"Hu MJ, Zhang C, Liang L, Wang SY, Zheng XC, Zhang Q, Jiang CX, Zhong Q, Huang F (2019) Fasting serum glucose, thyroid-stimulating hormone, and thyroid hormones and risk of papillary thyroid cancer: a case-control study. Head Neck 7:2277\u20132284. https:\/\/doi.org\/10.1002\/hed.25691","journal-title":"Head Neck"},{"key":"2785_CR22","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1002\/cam4.3970","volume":"13","author":"M Zhai","year":"2021","unstructured":"Zhai M, Zhang D, Long J, Gong Y, Ye F, Liu S, Li Y (2021) The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories: a systematic analysis for the global burden of disease study. Cancer Med 13:4542\u20134554. https:\/\/doi.org\/10.1002\/cam4.3970","journal-title":"Cancer Med"},{"key":"2785_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082164","author":"C Nyl\u00e9n","year":"2020","unstructured":"Nyl\u00e9n C, Mechera R, Mar\u00e9chal-Ross I, Tsang V, Chou A, Gill AJ, Clifton-Bligh RJ, Robinson BG, Sywak MS, Sidhu SB, Glover AR (2020) Molecular markers guiding thyroid cancer management. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers12082164","journal-title":"Cancers (Basel)"},{"key":"2785_CR24","doi-asserted-by":"publisher","DOI":"10.1210\/er.2017-00133","author":"EJ de Koster","year":"2018","unstructured":"de Koster EJ, de Geus-Oei LF, Dekkers OM, van Engen- Grunsven I, Hamming J, Corssmit EPM, Morreau H, Schepers A, Smit J, Oyen WJG, Vriens D (2018) Diagnostic utility of molecular and imaging biomarkers in cytological indeterminate thyroid nodules. Endocr Rev. https:\/\/doi.org\/10.1210\/er.2017-00133","journal-title":"Endocr Rev"},{"key":"2785_CR25","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042220-015032","author":"K Kobaly","year":"2022","unstructured":"Kobaly K, Kim CS, Mandel SJ (2022) Contemporary management of thyroid nodules. Annu Rev Med. https:\/\/doi.org\/10.1146\/annurev-med-042220-015032","journal-title":"Annu Rev Med"},{"key":"2785_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.801200","volume":"9","author":"IA Richard","year":"2021","unstructured":"Richard IA, Burgess JT, O\u2019Byrne KJ, Bolderson E (2021) Beyond PARP1: the potential of other members of the poly (ADP-ribose) polymerase family in DNA repair and cancer therapeutics. Front Cell Dev Biol 801200. https:\/\/doi.org\/10.3389\/fcell.2021.801200","journal-title":"Front Cell Dev Biol"},{"key":"2785_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41573-020-0076-6","volume":"10","author":"NJ Curtin","year":"2020","unstructured":"Curtin NJ, Szabo C (2020) Poly(ADP-ribose) polymerase inhibition: past, present and future. Nat Rev Drug Discov 10:711\u2013736. https:\/\/doi.org\/10.1038\/s41573-020-0076-6","journal-title":"Nat Rev Drug Discov"},{"key":"2785_CR28","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1083\/jcb.146.5.917","volume":"5","author":"VA Kickhoefer","year":"1999","unstructured":"Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, Rome LH (1999) The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 5:917\u2013928. https:\/\/doi.org\/10.1083\/jcb.146.5.917","journal-title":"J Cell Biol"},{"key":"2785_CR29","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/138945006778019345","volume":"8","author":"E Steiner","year":"2006","unstructured":"Steiner E, Holzmann K, Elbling L, Micksche M, Berger W (2006) Cellular functions of vaults and their involvement in multidrug resistance. Curr Drug Targets 8:923\u2013934. https:\/\/doi.org\/10.2174\/138945006778019345","journal-title":"Curr Drug Targets"},{"key":"2785_CR30","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1088877","volume":"5645","author":"IA Manke","year":"2003","unstructured":"Manke IA, Lowery DM, Nguyen A, Yaffe MB (2003) BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 5645:636\u2013639. https:\/\/doi.org\/10.1126\/science.1088877","journal-title":"Science"},{"key":"2785_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2014.05.003","author":"D Perina","year":"2014","unstructured":"Perina D, Miko\u010d A, Ahel J, \u0106etkovi\u0107 H, \u017daja R, Ahel I (2014) Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life. DNA Repair. https:\/\/doi.org\/10.1016\/j.dnarep.2014.05.003","journal-title":"DNA Repair"},{"key":"2785_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1530\/erc-15-0359","volume":"3","author":"Y Ikeda","year":"2016","unstructured":"Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap KL, Nielsen SM, Mester JL, Eng C, Nakamura Y, Grogan RH (2016) Germline PARP4 mutations in patients with primary thyroid and breast cancers. Endocr Relat Cancer 3:171\u2013179. https:\/\/doi.org\/10.1530\/erc-15-0359","journal-title":"Endocr Relat Cancer"},{"key":"2785_CR33","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-019-05286-w","volume":"1","author":"A Prawira","year":"2019","unstructured":"Prawira A, Munusamy P, Yuan J, Chan CHT, Koh GL, Shuen TWH, Hu J, Yap YS, Tan MH, Ang P, Lee ASG (2019) Assessment of PARP4 as a candidate breast cancer susceptibility gene. Breast Cancer Res Treat 1:145\u2013153. https:\/\/doi.org\/10.1007\/s10549-019-05286-w","journal-title":"Breast Cancer Res Treat"},{"key":"2785_CR34","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1158\/0008-5472.Can-05-0770","volume":"19","author":"S Raval-Fernandes","year":"2005","unstructured":"Raval-Fernandes S, Kickhoefer VA, Kitchen C, Rome LH (2005) Increased susceptibility of vault poly(ADP-ribose) polymerase-deficient mice to carcinogen-induced tumorigenesis. Cancer Res 19:8846\u20138852. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-0770","journal-title":"Cancer Res"},{"key":"2785_CR35","doi-asserted-by":"publisher","DOI":"10.2147\/ijgm.S343839","author":"J Zhan","year":"2021","unstructured":"Zhan J, Wu S, Zhao X, Jing J (2021) A novel DNA damage repair-related gene signature for predicting glioma prognosis. Int J Gen Med. https:\/\/doi.org\/10.2147\/ijgm.S343839","journal-title":"Int J Gen Med"},{"key":"2785_CR36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5483\/BMBRep.2022-0202","volume":"6","author":"HY Sung","year":"2023","unstructured":"Sung HY, Han J, Chae YJ, Ju W, Lee Kang J, Park AK, Ahn JH (2023) Identification of a novel PARP4 gene promoter CpG locus associated with cisplatin chemoresistance. BMB Rep 6:347\u2013352. https:\/\/doi.org\/10.5483\/BMBRep.2022-0202","journal-title":"BMB Rep"},{"issue":"1","key":"2785_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0333-7","volume":"9","author":"T Kling","year":"2017","unstructured":"Kling T, Wenger A, Beck S, Car\u00e9n H (2017) Validation of the MethylationEPIC BeadChip for fresh-frozen and formalin-fixed paraffin-embedded tumours. Clin Epigenetics 33. https:\/\/doi.org\/10.1186\/s13148-017-0333-7","journal-title":"Clin Epigenetics"},{"key":"2785_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/epi.15.114","volume":"3","author":"S Moran","year":"2016","unstructured":"Moran S, Arribas C, Esteller M (2016) Validation of a DNA methylation microarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 3:389\u2013399. https:\/\/doi.org\/10.2217\/epi.15.114","journal-title":"Epigenomics"},{"key":"2785_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ng1972","author":"JE Ohm","year":"2007","unstructured":"Ohm JE, McGarvey KM, Yu X, Cheng L, Schuebel KE, Cope L, Mohammad HP, Chen W, Daniel VC, Yu W, Berman DM, Jenuwein T, Pruitt K, Sharkis SJ, Watkins DN, Herman JG, Baylin SB (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet. https:\/\/doi.org\/10.1038\/ng1972","journal-title":"Nat Genet"},{"key":"2785_CR40","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40618-015-0246-2","volume":"7","author":"S Keelawat","year":"2015","unstructured":"Keelawat S, Thorner PS, Shuangshoti S, Bychkov A, Kitkumthorn N, Rattanatanyong P, Boonyayothin W, Poumsuk U, Ruangvejvorachai P, Mutirangura A (2015) Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis. J Endocrinol Invest 7:725\u2013732. https:\/\/doi.org\/10.1007\/s40618-015-0246-2","journal-title":"J Endocrinol Invest"},{"key":"2785_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5539\/cco.v4n2p1","volume":"2","author":"JK Stephen","year":"2015","unstructured":"Stephen JK, Chen KM, Merritt J, Chitale D, Divine G, Worsham MJ (2015) Methylation markers for early detection and differentiation of follicular thyroid cancer subtypes. Cancer Clin Oncol 2:1\u201312. https:\/\/doi.org\/10.5539\/cco.v4n2p1","journal-title":"Cancer Clin Oncol"},{"key":"2785_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.01702","volume":"10","author":"L Du","year":"2020","unstructured":"Du L, Zhao Z, Zheng R, Li H, Zhang S, Li R, Wei W, He J (2020) Epidemiology of thyroid cancer: incidence and mortality in China, 2015. Front Oncol 1702. https:\/\/doi.org\/10.3389\/fonc.2020.01702","journal-title":"Front Oncol"},{"key":"2785_CR43","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.2217\/fon.10.127","volume":"11","author":"R Rahbari","year":"2010","unstructured":"Rahbari R, Zhang L, Kebebew E (2010) Thyroid cancer gender disparity. Future Oncol 11:1771\u20131779. https:\/\/doi.org\/10.2217\/fon.10.127","journal-title":"Future Oncol"},{"key":"2785_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.738213","volume":"12","author":"F Cheng","year":"2021","unstructured":"Cheng F, Xiao J, Shao C, Huang F, Wang L, Ju Y, Jia H (2021) Burden of thyroid cancer from 1990 to 2019 and projections of incidence and mortality until 2039 in China: findings from Global Burden of Disease Study. Front Endocrinol (Lausanne) 738213. https:\/\/doi.org\/10.3389\/fendo.2021.738213","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2785_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c150027","author":"TM Ortiga-Carvalho","year":"2016","unstructured":"Ortiga-Carvalho TM, Chiamolera MI, Pazos-Moura CC, Wondisford FE (2016) Hypothalamus-pituitary-thyroid axis. Compr Physiol. https:\/\/doi.org\/10.1002\/cphy.c150027","journal-title":"Compr Physiol"},{"key":"2785_CR46","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1210\/jc.2012-1083","volume":"8","author":"DS McLeod","year":"2012","unstructured":"McLeod DS, Watters KF, Carpenter AD, Ladenson PW, Cooper DS, Ding EL (2012) Thyrotropin and thyroid cancer diagnosis: a systematic review and dose-response meta-analysis. J Clin Endocrinol Metab 8:2682\u20132692. https:\/\/doi.org\/10.1210\/jc.2012-1083","journal-title":"J Clin Endocrinol Metab"},{"key":"2785_CR47","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s12032-010-9587-z","volume":"4","author":"J Mohammadi-asl","year":"2011","unstructured":"Mohammadi-asl J, Larijani B, Khorgami Z, Tavangar SM, Haghpanah V, Kheirollahi M, Mehdipour P (2011) Qualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RAR\u03b22 genes in papillary thyroid carcinoma. Med Oncol 4:1123\u20131128. https:\/\/doi.org\/10.1007\/s12032-010-9587-z","journal-title":"Med Oncol"},{"key":"2785_CR48","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/labinvest.3700306","volume":"9","author":"N Nakamura","year":"2005","unstructured":"Nakamura N, Carney JA, Jin L, Kajita S, Pallares J, Zhang H, Qian X, Sebo TJ, Erickson LA, Lloyd RV (2005) RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors. Lab Invest 9:1065\u20131075. https:\/\/doi.org\/10.1038\/labinvest.3700306","journal-title":"Lab Invest"},{"key":"2785_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-79","volume":"13","author":"JC Santos","year":"2013","unstructured":"Santos JC, Bastos AU, Cerutti JM, Ribeiro ML (2013) Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma. BMC Cancer 79. https:\/\/doi.org\/10.1186\/1471-2407-13-79","journal-title":"BMC Cancer"},{"key":"2785_CR50","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1158\/0008-5472.can-03-3242","volume":"5","author":"M Xing","year":"2004","unstructured":"Xing M, Cohen Y, Mambo E, Tallini G, Udelsman R, Ladenson PW, Sidransky D (2004) Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res 5:1664\u20131668. https:\/\/doi.org\/10.1158\/0008-5472.can-03-3242","journal-title":"Cancer Res"},{"key":"2785_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.20945\/2359-3997000000330","volume":"2","author":"KC Peres","year":"2021","unstructured":"Peres KC, Teodoro L, Amaral LHP, Teixeira ES, Barreto IS, de Freitas LLL, Maximo V, Assump\u00e7\u00e3o LVM, Bufalo NE, Ward LS (2021) Clinical utility of TGFB1 and its receptors (TGFBR1 and TGFBR2) in thyroid nodules: evaluation based on single nucleotide polymorphisms and mRNA analysis. Arch Endocrinol Metab 2:172\u2013184. https:\/\/doi.org\/10.20945\/2359-3997000000330","journal-title":"Arch Endocrinol Metab"},{"key":"2785_CR52","doi-asserted-by":"publisher","DOI":"10.62347\/tznw3776","author":"X Liu","year":"2025","unstructured":"Liu X, Liu Y (2025) Expression patterns and diagnostic efficacy of cytokeratin 19 and galectin-3 in thyroid neoplasms. Int J Clin Exp Pathol. https:\/\/doi.org\/10.62347\/tznw3776","journal-title":"Int J Clin Exp Pathol"},{"key":"2785_CR53","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12902-024-01669-3","volume":"1","author":"MS Alwehaidah","year":"2024","unstructured":"Alwehaidah MS, Al-Awadhi R, Roomy MA, Baqer TA (2024) Mitochondrial DNA copy number and risk of papillary thyroid carcinoma. BMC Endocr Disord 1:138. https:\/\/doi.org\/10.1186\/s12902-024-01669-3","journal-title":"BMC Endocr Disord"},{"issue":"44","key":"2785_CR54","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000035542","volume":"102","author":"J Xu","year":"2023","unstructured":"Xu J, Liu W, Li R, Wang Y (2023) Significance of LINC02082 and LOC105369812 in differentiating papillary thyroid cancer from benign nodules. Medicine (Baltimore) (44):e35542. https:\/\/doi.org\/10.1097\/md.0000000000035542","journal-title":"Medicine (Baltimore)"},{"key":"2785_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.827811","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W, Zhang X, Zhu X, Cui W, Ye D, Tong G, Huang D, Zhou J, Lai X, Yan G, Li X, Fan J, Zhu H, Lei C (2022) Seven DNA methylation biomarker prediction models for monitoring the malignant progression from advanced adenoma to colorectal cancer. Front Oncol 827811. https:\/\/doi.org\/10.3389\/fonc.2022.827811","journal-title":"Front Oncol"},{"key":"2785_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.674338","volume":"8","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xia F, Jiang B, Wang W, Li X (2021) Role of immune cell-specific hypermethylation signatures in classification and risk stratification of breast cancer. Front Med (Lausanne) 674338. https:\/\/doi.org\/10.3389\/fmed.2021.674338","journal-title":"Front Med (Lausanne)"},{"key":"2785_CR57","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1158\/1055-9965.Epi-16-0845","volume":"8","author":"H Huang","year":"2017","unstructured":"Huang H, Rusiecki J, Zhao N, Chen Y, Ma S, Yu H, Ward MH, Udelsman R, Zhang Y (2017) Thyroid-stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 8:1209\u20131218. https:\/\/doi.org\/10.1158\/1055-9965.Epi-16-0845","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02785-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02785-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02785-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T12:47:25Z","timestamp":1775479645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02785-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["2785"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02785-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics declarations"}},{"value":"The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the Nanjing Medical University (No. 2020528), and written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}